Transaction Details

Footnotes

Represents a sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 10, 2024 (the "10b5-1 Plan"). The 10b5-1 Plan is scheduled to terminate on March 31, 2026, and covers the sale of up to an aggregate of 205,000 shares of the Issuer's common stock. Trading under the 10b5-1 Plan did not commence until at least 90 days following the date on which the plan was entered. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.1601 to $11.3100 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.